Analysis for EOG
$152.62
-1.57
(-1.02%)
- 📈 Growth — 28/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 18/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 6/10
Overall Score: 82/100
Summary:
📈 Growth & Financial Trajectory
Over eight quarters from 2024 Q3 to 2026 Q2, Revenue rose from about $5.97B to $8.62B and Net Income grew from about $1.25B to $2.72B, with acceleration into 2026 Q1–Q2. The sequence shows an overall uptrend despite a dip in 2024 Q4, underscoring improving operating leverage and earnings quality.
💰 Margins & Cash Flow
- Operating Margin expanded from the high-20s% to roughly 41% by 2026 Q2, reflecting stronger profitability.
- Net Cash Flow From Operating Activities climbed from the $2.0–2.6B range in 2024–2025 quarters to about $4.67B in 2026 Q2; investing cash flow remained negative as capex persists, with Net Cash Flow turning positive in several quarters.
🛡️ Balance Sheet & Liquidity
- Current ratio around 1.8x (Current Assets ~$9.88B vs Current Liabilities ~$5.34B).
- Debt burden modest (Liabilities ~$22.92B vs Equity ~$31.86B; Debt/Equity ~0.72).
- Total assets ~$54.8B; healthy equity base supports resilience.
⚠️ Key Drivers & Risks
- Drivers: Elevated commodity prices and disciplined cost management drive margins; favorable operating leverage.
- Risks: Commodity price cycles and capex sensitivity; regulatory/commodity volatility impacting cash flows.
📊 Key Financial Fundamentals
Valuation Multiples
Market Cap
$76.30B
P/E Ratio
11.10
Forward P/E
9.33
P/S Ratio
2.83
P/B Ratio
2.17
EV / EBITDA
5.77
Profitability & Returns
Gross Margin
79.47%
Operating Margin
33.02%
Net Margin
25.49%
ROE
22.38%
ROIC
17.82%
Financial Health & Liquidity
Current Ratio
1.85
Quick Ratio
1.68
Financial Scale & Cash Flow
Revenue
$26.97B
Net Income
$6.87B
FCF Yield
8.67%
Free Cash Flow
$6.61B
Total Debt To Equity
0.25